Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ashwagandha Extract as Adjuvant Therapy in Schizophrenia
NCT07575516Phase 2Completed
- Sponsor
- Hasanuddin University
- Start
- Oct 2025
- Primary completion
- Jan 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of withania somnifera in schizophrenia, sponsored by Hasanuddin University. Started Oct 2025; status: completed.
02
Drugs
withania somnifera
03
Conditions
schizophrenia
Beyond the preview
Go deeper on NCT07575516.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07575516.